217 related articles for article (PubMed ID: 21878516)
21. Etiologic factors in Paget's disease of bone.
Reddy SV
Cell Mol Life Sci; 2006 Feb; 63(4):391-8. PubMed ID: 16429324
[TBL] [Abstract][Full Text] [Related]
22. A FKBP5 mutation is associated with Paget's disease of bone and enhances osteoclastogenesis.
Lu B; Jiao Y; Wang Y; Dong J; Wei M; Cui B; Sun Y; Wang L; Zhang B; Chen Z; Zhao Y
Exp Mol Med; 2017 May; 49(5):e336. PubMed ID: 28524179
[TBL] [Abstract][Full Text] [Related]
23. Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of bone.
Stephens E; Roy M; Bisson M; Nguyen HD; Scott MS; Boire G; Bouchard L; Roux S
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165852. PubMed ID: 32485219
[TBL] [Abstract][Full Text] [Related]
24. Mutant p62/SQSTM1 UBA domains linked to Paget's disease of bone differ in their abilities to function as stabilization signals.
Heinen C; Garner TP; Long J; Böttcher C; Ralston SH; Cavey JR; Searle MS; Layfield R; Dantuma NP
FEBS Lett; 2010 Apr; 584(8):1585-90. PubMed ID: 20230821
[TBL] [Abstract][Full Text] [Related]
25. Alternative splicing in osteoclasts and Paget's disease of bone.
Klinck R; Laberge G; Bisson M; McManus S; Michou L; Brown JP; Roux S
BMC Med Genet; 2014 Aug; 15():98. PubMed ID: 25115182
[TBL] [Abstract][Full Text] [Related]
26. Osteoclast differentiation from circulating mononuclear precursors in Paget's disease is hypersensitive to 1,25-dihydroxyvitamin D(3) and RANKL.
Neale SD; Smith R; Wass JA; Athanasou NA
Bone; 2000 Sep; 27(3):409-16. PubMed ID: 10962353
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a non-UBA domain missense mutation of sequestosome 1 (SQSTM1) in Paget's disease of bone.
Najat D; Garner T; Hagen T; Shaw B; Sheppard PW; Falchetti A; Marini F; Brandi ML; Long JE; Cavey JR; Searle MS; Layfield R
J Bone Miner Res; 2009 Apr; 24(4):632-42. PubMed ID: 19049332
[TBL] [Abstract][Full Text] [Related]
28. Impact of p62/SQSTM1 UBA domain mutations linked to Paget's disease of bone on ubiquitin recognition.
Garner TP; Long J; Layfield R; Searle MS
Biochemistry; 2011 May; 50(21):4665-74. PubMed ID: 21517082
[TBL] [Abstract][Full Text] [Related]
29. Genetics of Paget's disease of bone.
Daroszewska A; Ralston SH
Clin Sci (Lond); 2005 Sep; 109(3):257-63. PubMed ID: 16104845
[TBL] [Abstract][Full Text] [Related]
30. Role of ATF7-TAF12 interactions in the vitamin D response hypersensitivity of osteoclast precursors in Paget's disease.
Teramachi J; Hiruma Y; Ishizuka S; Ishizuka H; Brown JP; Michou L; Cao H; Galson DL; Subler MA; Zhou H; Dempster DW; Windle JJ; Roodman GD; Kurihara N
J Bone Miner Res; 2013 Jun; 28(6):1489-500. PubMed ID: 23426901
[TBL] [Abstract][Full Text] [Related]
31. Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype.
Kurihara N; Reddy SV; Menaa C; Anderson D; Roodman GD
J Clin Invest; 2000 Mar; 105(5):607-14. PubMed ID: 10712432
[TBL] [Abstract][Full Text] [Related]
32. Optineurin Negatively Regulates Osteoclast Differentiation by Modulating NF-κB and Interferon Signaling: Implications for Paget's Disease.
Obaid R; Wani SE; Azfer A; Hurd T; Jones R; Cohen P; Ralston SH; Albagha OME
Cell Rep; 2015 Nov; 13(6):1096-1102. PubMed ID: 26527009
[TBL] [Abstract][Full Text] [Related]
33. Gene-environment interactions in Paget's disease of bone.
Numan MS; Jean S; Dessay M; Gagnon E; Amiable N; Brown JP; Michou L
Joint Bone Spine; 2019 May; 86(3):373-380. PubMed ID: 30594595
[TBL] [Abstract][Full Text] [Related]
34. SOCS-1/3 participation in FGF-2 signaling to modulate RANK ligand expression in paget's disease of bone.
Sundaram K; Senn J; Reddy SV
J Cell Biochem; 2013 Sep; 114(9):2032-8. PubMed ID: 23553658
[TBL] [Abstract][Full Text] [Related]
35. p62 mutations, ubiquitin recognition and Paget's disease of bone.
Layfield R; Cavey JR; Najat D; Long J; Sheppard PW; Ralston SH; Searle MS
Biochem Soc Trans; 2006 Nov; 34(Pt 5):735-7. PubMed ID: 17052185
[TBL] [Abstract][Full Text] [Related]
36. Rare Inherited forms of Paget's Disease and Related Syndromes.
Ralston SH; Taylor JP
Calcif Tissue Int; 2019 May; 104(5):501-516. PubMed ID: 30756140
[TBL] [Abstract][Full Text] [Related]
37. Shikimic Acid Inhibits Osteoclastogenesis in Vivo and in Vitro by Blocking RANK/TRAF6 Association and Suppressing NF-κB and MAPK Signaling Pathways.
Chen X; Li X; Zhai X; Zhi X; Cao L; Qin L; Su J
Cell Physiol Biochem; 2018; 51(6):2858-2871. PubMed ID: 30562759
[TBL] [Abstract][Full Text] [Related]
38. New knowledge on critical osteoclast formation and activation pathways from study of rare genetic diseases of osteoclasts: focus on the RANK/RANKL axis.
Crockett JC; Mellis DJ; Scott DI; Helfrich MH
Osteoporos Int; 2011 Jan; 22(1):1-20. PubMed ID: 20458572
[TBL] [Abstract][Full Text] [Related]
39. Structure of the ubiquitin-associated domain of p62 (SQSTM1) and implications for mutations that cause Paget's disease of bone.
Ciani B; Layfield R; Cavey JR; Sheppard PW; Searle MS
J Biol Chem; 2003 Sep; 278(39):37409-12. PubMed ID: 12857745
[TBL] [Abstract][Full Text] [Related]
40. Paget disease of bone-associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function.
Goode A; Long JE; Shaw B; Ralston SH; Visconti MR; Gianfrancesco F; Esposito T; Gennari L; Merlotti D; Rendina D; Rea SL; Sultana M; Searle MS; Layfield R
Biochim Biophys Acta; 2014 Jul; 1842(7):992-1000. PubMed ID: 24642144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
